510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1180-2017Class II

Merge RadSuite software. The firm name on the label is Merge Healthcare, Hartland, WI

Merge Healthcare Incorporated / initiated 2015-11-17 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of Merge RadSuite software. The firm name on the label is Merge Healthcare, Hartland, WI on . FDA classified it as Class II and gives the reason as "The values provided from the Pixel Value tool do not appear to be correct, which may result in potential patient injury or delay in diagnosis or treatment". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1180-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
Merge RadSuite software. The firm name on the label is Merge Healthcare, Hartland, WI.
Product code
LLZ System, Image Processing, Radiological
Reason for recall
The values provided from the Pixel Value tool do not appear to be correct, which may result in potential patient injury or delay in diagnosis or treatment.
Root cause tag
software
FDA root cause
Software design
Action
Merge sent an Urgent Medical Device Recall letter dated March 28, 2016 to all affected customers. The letter notifies the customer of the issue and informs them an upgrade is available. The notification instructs the customer to pass the information onto all other users, as well as any downstream customers if it was further distributed. The notification also informs the customer their response is required using the enclosed form and the return addressed envelope. The response form asks, in part, if they are interested in accepting the fix. If they decline the fix, they are asked to provide the reason why. The response was required no later than April 18, 2016. A second letter dated July 11, 2016, was issued asking for a response by August 2, 2016, even though all upgrades were made because the effectiveness checks were not yet completed. The letter and response form contained the same information as the first letter. The recalling firm reported emails were tracked for delivery confirmation and the letters were tracked for delivery by USPS certified services. For further questions, please call 877-744-5369.
Quantity in commerce
8 sites have the potentially affected version
Distribution
US Distribution was made to medical facilities in AL, IN, MI, PA and WI.
Product codes and lots
Version V8.30.7.8

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1180-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1180-2017Class IITerminatedVoluntary: Firm initiated